0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Androstenedione Market Research Report 2026
Published Date: 2026-02-05
|
Report Code: QYRE-Auto-36V6758
Home | Market Reports | Health| Pharmacy
Global Androstenedione Market Insights and Forecast to 2028
BUY CHAPTERS

Global Androstenedione Market Research Report 2026

Code: QYRE-Auto-36V6758
Report
2026-02-05
Pages:125
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Androstenedione Market Size

The global Androstenedione market was valued at US$ 217 million in 2025 and is anticipated to reach US$ 262 million by 2032, at a CAGR of 2.8% from 2026 to 2032.

Androstenedione Market

Androstenedione Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Androstenedione competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Androstenedione: 4-Androstenedione (androst-4-ene-3,17-dione) – an endogenous weak androgen and estrogen and intermediate to/prohormone of testosterone.
Androstenedione is used to evaluate the function of the adrenal gland and the ovaries or the testicles as well as the production of hormones related to the development of male sex organs and physical characteristics (androgens). It is most commonly used to determine the cause of symptoms of excess androgens in a woman who has an elevated testosterone level, along with a few other laboratory tests for this purpose.
Androstadienedione (1,4-androstadiene-3,17-dione) is an important industrial precursor for various steroid hormones. Androstadienedione is an important industrial-scale precursor for a wide variety of steroid hormones within the estrane and androstane classifications.
In the report, the data bases on androstenedione and androstadienedione.
Androstenedione production is concentrated relatively. Currently, there are several producing companies in the world androstenedione industry. The main market players are BIOVET, Indo Phyto Chemicals, Sito Bio, Goto Pharmaceutical, Tianjin King York and Jiufu. Tianjin King York is the leader in the global market, with about 16% market shares.
China is the largest production region and the share reached 77.68% in 2015. The shares of Europe, India and Asia Other were 11.51%, 2.58% and 2.79%.
This report delivers a comprehensive overview of the global Androstenedione market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Androstenedione. The Androstenedione market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Androstenedione market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Androstenedione manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Androstenedione Market Report

Report Metric Details
Report Name Androstenedione Market
Accounted market size in 2025 US$ 217 million
Forecasted market size in 2032 US$ 262 million
CAGR 2.8%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Androstenedione
  • Androstadienedione
by Application
  • Arthritis Pharmaceuticals
  • Fertility Control Pharmaceuticals
  • Infectious Inflammation Pharmaceuticals
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company BIOVET, Indo Phyto Chemicals, Sito Bio, Goto Pharmaceutical, Tianjin King York, Jiufu, Yongning Pharma, Jiangxi Hongyuan Pharmaceutical, Kaizon, Xi’an Gaoyuan Bio-Chem, Dongyao Pharmaceutical, Huazhong Pharmaceutical, Darui, Danjiangkou Danao, Dahua Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Androstenedione manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Androstenedione sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Androstenedione Market growing?

Ans: The Androstenedione Market witnessing a CAGR of 2.8% during the forecast period 2026-2032.

What is the Androstenedione Market size in 2032?

Ans: The Androstenedione Market size in 2032 will be US$ 262 million.

What is the Tianjin King York share in Androstenedione Market?

Ans: Tianjin King York is the leader in the global market, with about 16% market shares.

What is the Androstenedione Market production share by region?

Ans: China is the largest production region and the share reached 77.68% in 2015.

Who are the main players in the Androstenedione Market report?

Ans: The main players in the Androstenedione Market are BIOVET, Indo Phyto Chemicals, Sito Bio, Goto Pharmaceutical, Tianjin King York, Jiufu, Yongning Pharma, Jiangxi Hongyuan Pharmaceutical, Kaizon, Xi’an Gaoyuan Bio-Chem, Dongyao Pharmaceutical, Huazhong Pharmaceutical, Darui, Danjiangkou Danao, Dahua Pharmaceutical

What are the Application segmentation covered in the Androstenedione Market report?

Ans: The Applications covered in the Androstenedione Market report are Arthritis Pharmaceuticals, Fertility Control Pharmaceuticals, Infectious Inflammation Pharmaceuticals, Others

What are the Type segmentation covered in the Androstenedione Market report?

Ans: The Types covered in the Androstenedione Market report are Androstenedione, Androstadienedione

1 Androstenedione Market Overview
1.1 Product Definition
1.2 Androstenedione by Type
1.2.1 Global Androstenedione Market Value by Type: 2025 vs 2032
1.2.2 Androstenedione
1.2.3 Androstadienedione
1.3 Androstenedione by Application
1.3.1 Global Androstenedione Market Value by Application: 2025 vs 2032
1.3.2 Arthritis Pharmaceuticals
1.3.3 Fertility Control Pharmaceuticals
1.3.4 Infectious Inflammation Pharmaceuticals
1.3.5 Others
1.4 Global Androstenedione Market Size Estimates and Forecasts
1.4.1 Global Androstenedione Revenue 2021–2032
1.4.2 Global Androstenedione Sales 2021–2032
1.4.3 Global Androstenedione Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Androstenedione Market Competition by Manufacturers
2.1 Global Androstenedione Sales Market Share by Manufacturers (2021–2026)
2.2 Global Androstenedione Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Androstenedione Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Androstenedione, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Androstenedione, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Androstenedione, Product Types and Applications
2.7 Global Key Manufacturers of Androstenedione, Date of Entry into the Industry
2.8 Global Androstenedione Market Competitive Situation and Trends
2.8.1 Global Androstenedione Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Androstenedione Players Market Share by Revenue
2.8.3 Global Androstenedione Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Androstenedione Market Scenario by Region
3.1 Global Androstenedione Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Androstenedione Sales by Region: 2021–2032
3.2.1 Global Androstenedione Sales by Region: 2021–2026
3.2.2 Global Androstenedione Sales by Region: 2027–2032
3.3 Global Androstenedione Revenue by Region: 2021–2032
3.3.1 Global Androstenedione Revenue by Region: 2021–2026
3.3.2 Global Androstenedione Revenue by Region: 2027–2032
3.4 North America Androstenedione Market Facts & Figures by Country
3.4.1 North America Androstenedione Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Androstenedione Sales by Country (2021–2032)
3.4.3 North America Androstenedione Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Androstenedione Market Facts & Figures by Country
3.5.1 Europe Androstenedione Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Androstenedione Sales by Country (2021–2032)
3.5.3 Europe Androstenedione Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Androstenedione Market Facts & Figures by Region
3.6.1 Asia Pacific Androstenedione Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Androstenedione Sales by Region (2021–2032)
3.6.3 Asia Pacific Androstenedione Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Androstenedione Market Facts & Figures by Country
3.7.1 Latin America Androstenedione Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Androstenedione Sales by Country (2021–2032)
3.7.3 Latin America Androstenedione Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Androstenedione Market Facts & Figures by Country
3.8.1 Middle East and Africa Androstenedione Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Androstenedione Sales by Country (2021–2032)
3.8.3 Middle East and Africa Androstenedione Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Androstenedione Sales by Type (2021–2032)
4.1.1 Global Androstenedione Sales by Type (2021–2026)
4.1.2 Global Androstenedione Sales by Type (2027–2032)
4.1.3 Global Androstenedione Sales Market Share by Type (2021–2032)
4.2 Global Androstenedione Revenue by Type (2021–2032)
4.2.1 Global Androstenedione Revenue by Type (2021–2026)
4.2.2 Global Androstenedione Revenue by Type (2027–2032)
4.2.3 Global Androstenedione Revenue Market Share by Type (2021–2032)
4.3 Global Androstenedione Price by Type (2021–2032)
5 Segment by Application
5.1 Global Androstenedione Sales by Application (2021–2032)
5.1.1 Global Androstenedione Sales by Application (2021–2026)
5.1.2 Global Androstenedione Sales by Application (2027–2032)
5.1.3 Global Androstenedione Sales Market Share by Application (2021–2032)
5.2 Global Androstenedione Revenue by Application (2021–2032)
5.2.1 Global Androstenedione Revenue by Application (2021–2026)
5.2.2 Global Androstenedione Revenue by Application (2027–2032)
5.2.3 Global Androstenedione Revenue Market Share by Application (2021–2032)
5.3 Global Androstenedione Price by Application (2021–2032)
6 Key Companies Profiled
6.1 BIOVET
6.1.1 BIOVET Company Information
6.1.2 BIOVET Description and Business Overview
6.1.3 BIOVET Androstenedione Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 BIOVET Androstenedione Product Portfolio
6.1.5 BIOVET Recent Developments/Updates
6.2 Indo Phyto Chemicals
6.2.1 Indo Phyto Chemicals Company Information
6.2.2 Indo Phyto Chemicals Description and Business Overview
6.2.3 Indo Phyto Chemicals Androstenedione Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Indo Phyto Chemicals Androstenedione Product Portfolio
6.2.5 Indo Phyto Chemicals Recent Developments/Updates
6.3 Sito Bio
6.3.1 Sito Bio Company Information
6.3.2 Sito Bio Description and Business Overview
6.3.3 Sito Bio Androstenedione Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Sito Bio Androstenedione Product Portfolio
6.3.5 Sito Bio Recent Developments/Updates
6.4 Goto Pharmaceutical
6.4.1 Goto Pharmaceutical Company Information
6.4.2 Goto Pharmaceutical Description and Business Overview
6.4.3 Goto Pharmaceutical Androstenedione Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Goto Pharmaceutical Androstenedione Product Portfolio
6.4.5 Goto Pharmaceutical Recent Developments/Updates
6.5 Tianjin King York
6.5.1 Tianjin King York Company Information
6.5.2 Tianjin King York Description and Business Overview
6.5.3 Tianjin King York Androstenedione Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Tianjin King York Androstenedione Product Portfolio
6.5.5 Tianjin King York Recent Developments/Updates
6.6 Jiufu
6.6.1 Jiufu Company Information
6.6.2 Jiufu Description and Business Overview
6.6.3 Jiufu Androstenedione Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Jiufu Androstenedione Product Portfolio
6.6.5 Jiufu Recent Developments/Updates
6.7 Yongning Pharma
6.7.1 Yongning Pharma Company Information
6.7.2 Yongning Pharma Description and Business Overview
6.7.3 Yongning Pharma Androstenedione Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Yongning Pharma Androstenedione Product Portfolio
6.7.5 Yongning Pharma Recent Developments/Updates
6.8 Jiangxi Hongyuan Pharmaceutical
6.8.1 Jiangxi Hongyuan Pharmaceutical Company Information
6.8.2 Jiangxi Hongyuan Pharmaceutical Description and Business Overview
6.8.3 Jiangxi Hongyuan Pharmaceutical Androstenedione Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Jiangxi Hongyuan Pharmaceutical Androstenedione Product Portfolio
6.8.5 Jiangxi Hongyuan Pharmaceutical Recent Developments/Updates
6.9 Kaizon
6.9.1 Kaizon Company Information
6.9.2 Kaizon Description and Business Overview
6.9.3 Kaizon Androstenedione Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Kaizon Androstenedione Product Portfolio
6.9.5 Kaizon Recent Developments/Updates
6.10 Xi’an Gaoyuan Bio-Chem
6.10.1 Xi’an Gaoyuan Bio-Chem Company Information
6.10.2 Xi’an Gaoyuan Bio-Chem Description and Business Overview
6.10.3 Xi’an Gaoyuan Bio-Chem Androstenedione Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Xi’an Gaoyuan Bio-Chem Androstenedione Product Portfolio
6.10.5 Xi’an Gaoyuan Bio-Chem Recent Developments/Updates
6.11 Dongyao Pharmaceutical
6.11.1 Dongyao Pharmaceutical Company Information
6.11.2 Dongyao Pharmaceutical Description and Business Overview
6.11.3 Dongyao Pharmaceutical Androstenedione Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Dongyao Pharmaceutical Androstenedione Product Portfolio
6.11.5 Dongyao Pharmaceutical Recent Developments/Updates
6.12 Huazhong Pharmaceutical
6.12.1 Huazhong Pharmaceutical Company Information
6.12.2 Huazhong Pharmaceutical Description and Business Overview
6.12.3 Huazhong Pharmaceutical Androstenedione Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Huazhong Pharmaceutical Androstenedione Product Portfolio
6.12.5 Huazhong Pharmaceutical Recent Developments/Updates
6.13 Darui
6.13.1 Darui Company Information
6.13.2 Darui Description and Business Overview
6.13.3 Darui Androstenedione Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Darui Androstenedione Product Portfolio
6.13.5 Darui Recent Developments/Updates
6.14 Danjiangkou Danao
6.14.1 Danjiangkou Danao Company Information
6.14.2 Danjiangkou Danao Description and Business Overview
6.14.3 Danjiangkou Danao Androstenedione Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Danjiangkou Danao Androstenedione Product Portfolio
6.14.5 Danjiangkou Danao Recent Developments/Updates
6.15 Dahua Pharmaceutical
6.15.1 Dahua Pharmaceutical Company Information
6.15.2 Dahua Pharmaceutical Description and Business Overview
6.15.3 Dahua Pharmaceutical Androstenedione Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Dahua Pharmaceutical Androstenedione Product Portfolio
6.15.5 Dahua Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Androstenedione Industry Chain Analysis
7.2 Androstenedione Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Androstenedione Production Mode & Process Analysis
7.4 Androstenedione Sales and Marketing
7.4.1 Androstenedione Sales Channels
7.4.2 Androstenedione Distributors
7.5 Androstenedione Customer Analysis
8 Androstenedione Market Dynamics
8.1 Androstenedione Industry Trends
8.2 Androstenedione Market Drivers
8.3 Androstenedione Market Challenges
8.4 Androstenedione Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Androstenedione Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Androstenedione Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Androstenedione Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Androstenedione Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global Androstenedione Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Androstenedione Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Androstenedione Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Androstenedione Average Price (USD/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Androstenedione, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Androstenedione, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Androstenedione, Product Types and Applications
 Table 12. Global Key Manufacturers of Androstenedione, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Androstenedione Companies by Tier (Tier 1, Tier 2, Tier 3), based on Androstenedione Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Androstenedione Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Androstenedione Sales by Region (K Units), 2021–2026
 Table 18. Global Androstenedione Sales Market Share by Region (2021–2026)
 Table 19. Global Androstenedione Sales by Region (K Units), 2027–2032
 Table 20. Global Androstenedione Sales Market Share by Region (2027–2032)
 Table 21. Global Androstenedione Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Androstenedione Revenue Market Share by Region (2021–2026)
 Table 23. Global Androstenedione Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Androstenedione Revenue Market Share by Region (2027–2032)
 Table 25. North America Androstenedione Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Androstenedione Sales by Country (K Units), 2021–2026
 Table 27. North America Androstenedione Sales by Country (K Units), 2027–2032
 Table 28. North America Androstenedione Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Androstenedione Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Androstenedione Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Androstenedione Sales by Country (K Units), 2021–2026
 Table 32. Europe Androstenedione Sales by Country (K Units), 2027–2032
 Table 33. Europe Androstenedione Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Androstenedione Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Androstenedione Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Androstenedione Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific Androstenedione Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific Androstenedione Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Androstenedione Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Androstenedione Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Androstenedione Sales by Country (K Units), 2021–2026
 Table 42. Latin America Androstenedione Sales by Country (K Units), 2027–2032
 Table 43. Latin America Androstenedione Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Androstenedione Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Androstenedione Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Androstenedione Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa Androstenedione Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa Androstenedione Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Androstenedione Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Androstenedione Sales (K Units) by Type (2021–2026)
 Table 51. Global Androstenedione Sales (K Units) by Type (2027–2032)
 Table 52. Global Androstenedione Sales Market Share by Type (2021–2026)
 Table 53. Global Androstenedione Sales Market Share by Type (2027–2032)
 Table 54. Global Androstenedione Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Androstenedione Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Androstenedione Revenue Market Share by Type (2021–2026)
 Table 57. Global Androstenedione Revenue Market Share by Type (2027–2032)
 Table 58. Global Androstenedione Price (USD/Unit) by Type (2021–2026)
 Table 59. Global Androstenedione Price (USD/Unit) by Type (2027–2032)
 Table 60. Global Androstenedione Sales (K Units) by Application (2021–2026)
 Table 61. Global Androstenedione Sales (K Units) by Application (2027–2032)
 Table 62. Global Androstenedione Sales Market Share by Application (2021–2026)
 Table 63. Global Androstenedione Sales Market Share by Application (2027–2032)
 Table 64. Global Androstenedione Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Androstenedione Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Androstenedione Revenue Market Share by Application (2021–2026)
 Table 67. Global Androstenedione Revenue Market Share by Application (2027–2032)
 Table 68. Global Androstenedione Price (USD/Unit) by Application (2021–2026)
 Table 69. Global Androstenedione Price (USD/Unit) by Application (2027–2032)
 Table 70. BIOVET Company Information
 Table 71. BIOVET Description and Business Overview
 Table 72. BIOVET Androstenedione Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 73. BIOVET Androstenedione Product
 Table 74. BIOVET Recent Developments/Updates
 Table 75. Indo Phyto Chemicals Company Information
 Table 76. Indo Phyto Chemicals Description and Business Overview
 Table 77. Indo Phyto Chemicals Androstenedione Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 78. Indo Phyto Chemicals Androstenedione Product
 Table 79. Indo Phyto Chemicals Recent Developments/Updates
 Table 80. Sito Bio Company Information
 Table 81. Sito Bio Description and Business Overview
 Table 82. Sito Bio Androstenedione Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 83. Sito Bio Androstenedione Product
 Table 84. Sito Bio Recent Developments/Updates
 Table 85. Goto Pharmaceutical Company Information
 Table 86. Goto Pharmaceutical Description and Business Overview
 Table 87. Goto Pharmaceutical Androstenedione Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 88. Goto Pharmaceutical Androstenedione Product
 Table 89. Goto Pharmaceutical Recent Developments/Updates
 Table 90. Tianjin King York Company Information
 Table 91. Tianjin King York Description and Business Overview
 Table 92. Tianjin King York Androstenedione Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 93. Tianjin King York Androstenedione Product
 Table 94. Tianjin King York Recent Developments/Updates
 Table 95. Jiufu Company Information
 Table 96. Jiufu Description and Business Overview
 Table 97. Jiufu Androstenedione Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 98. Jiufu Androstenedione Product
 Table 99. Jiufu Recent Developments/Updates
 Table 100. Yongning Pharma Company Information
 Table 101. Yongning Pharma Description and Business Overview
 Table 102. Yongning Pharma Androstenedione Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 103. Yongning Pharma Androstenedione Product
 Table 104. Yongning Pharma Recent Developments/Updates
 Table 105. Jiangxi Hongyuan Pharmaceutical Company Information
 Table 106. Jiangxi Hongyuan Pharmaceutical Description and Business Overview
 Table 107. Jiangxi Hongyuan Pharmaceutical Androstenedione Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 108. Jiangxi Hongyuan Pharmaceutical Androstenedione Product
 Table 109. Jiangxi Hongyuan Pharmaceutical Recent Developments/Updates
 Table 110. Kaizon Company Information
 Table 111. Kaizon Description and Business Overview
 Table 112. Kaizon Androstenedione Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 113. Kaizon Androstenedione Product
 Table 114. Kaizon Recent Developments/Updates
 Table 115. Xi’an Gaoyuan Bio-Chem Company Information
 Table 116. Xi’an Gaoyuan Bio-Chem Description and Business Overview
 Table 117. Xi’an Gaoyuan Bio-Chem Androstenedione Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 118. Xi’an Gaoyuan Bio-Chem Androstenedione Product
 Table 119. Xi’an Gaoyuan Bio-Chem Recent Developments/Updates
 Table 120. Dongyao Pharmaceutical Company Information
 Table 121. Dongyao Pharmaceutical Description and Business Overview
 Table 122. Dongyao Pharmaceutical Androstenedione Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 123. Dongyao Pharmaceutical Androstenedione Product
 Table 124. Dongyao Pharmaceutical Recent Developments/Updates
 Table 125. Huazhong Pharmaceutical Company Information
 Table 126. Huazhong Pharmaceutical Description and Business Overview
 Table 127. Huazhong Pharmaceutical Androstenedione Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 128. Huazhong Pharmaceutical Androstenedione Product
 Table 129. Huazhong Pharmaceutical Recent Developments/Updates
 Table 130. Darui Company Information
 Table 131. Darui Description and Business Overview
 Table 132. Darui Androstenedione Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 133. Darui Androstenedione Product
 Table 134. Darui Recent Developments/Updates
 Table 135. Danjiangkou Danao Company Information
 Table 136. Danjiangkou Danao Description and Business Overview
 Table 137. Danjiangkou Danao Androstenedione Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 138. Danjiangkou Danao Androstenedione Product
 Table 139. Danjiangkou Danao Recent Developments/Updates
 Table 140. Dahua Pharmaceutical Company Information
 Table 141. Dahua Pharmaceutical Description and Business Overview
 Table 142. Dahua Pharmaceutical Androstenedione Sales (K Units), Revenue (US$ Million), Price (USD/Unit), and Gross Margin (2021–2026)
 Table 143. Dahua Pharmaceutical Androstenedione Product
 Table 144. Dahua Pharmaceutical Recent Developments/Updates
 Table 145. Key Raw Materials Lists
 Table 146. Raw Materials Key Suppliers Lists
 Table 147. Androstenedione Distributors List
 Table 148. Androstenedione Customers List
 Table 149. Androstenedione Market Trends
 Table 150. Androstenedione Market Drivers
 Table 151. Androstenedione Market Challenges
 Table 152. Androstenedione Market Restraints
 Table 153. Research Programs/Design for This Report
 Table 154. Key Data Information from Secondary Sources
 Table 155. Key Data Information from Primary Sources
 Table 156. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Androstenedione
 Figure 2. Global Androstenedione Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Androstenedione Market Share by Type: 2025 & 2032
 Figure 4. Androstenedione Product Picture
 Figure 5. Androstadienedione Product Picture
 Figure 6. Global Androstenedione Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global Androstenedione Market Share by Application: 2025 & 2032
 Figure 8. Arthritis Pharmaceuticals
 Figure 9. Fertility Control Pharmaceuticals
 Figure 10. Infectious Inflammation Pharmaceuticals
 Figure 11. Others
 Figure 12. Global Androstenedione Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 13. Global Androstenedione Market Size (US$ Million), 2021–2032
 Figure 14. Global Androstenedione Sales (K Units), 2021–2032
 Figure 15. Global Androstenedione Average Price (USD/Unit), 2021–2032
 Figure 16. Androstenedione Report Years Considered
 Figure 17. Androstenedione Sales Share by Manufacturers in 2025
 Figure 18. Global Androstenedione Revenue Share by Manufacturers in 2025
 Figure 19. Top 5 and Top 10 Global Androstenedione Players: Market Share by Revenue in Androstenedione in 2025
 Figure 20. Androstenedione Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 21. Global Androstenedione Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 22. North America Androstenedione Sales Market Share by Country (2021–2032)
 Figure 23. North America Androstenedione Revenue Market Share by Country (2021–2032)
 Figure 24. U.S. Androstenedione Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Canada Androstenedione Revenue Growth Rate (US$ Million), 2021–2032
 Figure 26. Europe Androstenedione Sales Market Share by Country (2021–2032)
 Figure 27. Europe Androstenedione Revenue Market Share by Country (2021–2032)
 Figure 28. Germany Androstenedione Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. France Androstenedione Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. U.K. Androstenedione Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Italy Androstenedione Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Russia Androstenedione Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Asia Pacific Androstenedione Sales Market Share by Region (2021–2032)
 Figure 34. Asia Pacific Androstenedione Revenue Market Share by Region (2021–2032)
 Figure 35. China Androstenedione Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. Japan Androstenedione Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. South Korea Androstenedione Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. India Androstenedione Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Australia Androstenedione Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Taiwan Androstenedione Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Indonesia Androstenedione Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Thailand Androstenedione Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Malaysia Androstenedione Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Philippines Androstenedione Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Latin America Androstenedione Sales Market Share by Country (2021–2032)
 Figure 46. Latin America Androstenedione Revenue Market Share by Country (2021–2032)
 Figure 47. Mexico Androstenedione Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Brazil Androstenedione Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Argentina Androstenedione Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Middle East and Africa Androstenedione Sales Market Share by Country (2021–2032)
 Figure 51. Middle East and Africa Androstenedione Revenue Market Share by Country (2021–2032)
 Figure 52. Turkey Androstenedione Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. Saudi Arabia Androstenedione Revenue Growth Rate (US$ Million), 2021–2032
 Figure 54. U.A.E Androstenedione Revenue Growth Rate (US$ Million), 2021–2032
 Figure 55. Global Sales Market Share of Androstenedione by Type (2021–2032)
 Figure 56. Global Revenue Market Share of Androstenedione by Type (2021–2032)
 Figure 57. Global Androstenedione Price (USD/Unit) by Type (2021–2032)
 Figure 58. Global Sales Market Share of Androstenedione by Application (2021–2032)
 Figure 59. Global Revenue Market Share of Androstenedione by Application (2021–2032)
 Figure 60. Global Androstenedione Price (USD/Unit) by Application (2021–2032)
 Figure 61. Androstenedione Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Leap India